Since our inception in 1995, Fred Hutch’s Antibody Technology shared resource has worked with research teams inside and outside the Hutch to design campaign strategies for the generation and identification of novel monoclonal antibody compositions. Our projects encompass a range of applications in oncology, viral therapeutics and diagnostics.
We offer full-service discovery, from target gene to antibody, in multiple host species, including mice, rats and hamsters. We use both traditional and DNA-based immunization strategies.
We can affinity purify up to 500 mg of research-grade IgG from serum-free hybridoma cultures.
Our characterization services include isotyping, variable domain sequencing, recombinant antibody validation, Western blot screening and high-throughput kinetics via Carterra LSA surface plasmon resonance.
We work with research teams to meet each project’s specific objectives. Guided by our team’s more than 65 years of combined experience and our commitment to scientific excellence, we will assist you in designing and executing the appropriate strategy for producing the reagent you need.
For service requests or other questions: Please submit an inquiry.